Meldungen sortieren nach Relevanz Meldungsdatum
|
Life Science Erfindungen der bayerischen Universitäten auf der BioVaria 2012
, Forschung und Entwicklung, Bayerische Patentallianz GmbH
Die Bayerische Patentallianz GmbH, die zentrale Patent- und Vermarktungsagentur von 28 bayerischen Universitäten und Hochschulen für angewandte Wissenschaften, präsentiert...
|
IDC Releases First Worldwide Big Data Technology and Services Market Forecast, Shows Big Data as the Next Essential Capability and a Foundation for the Intelligent Economy
, Events, IDC Central Europe GmbH
International Data Corporation (IDC) today released a worldwide Big Data technology and services forecast showing the market is expected to grow from $3.2 billion...
|
Gleich 3 neue Projekte starten im Münchner Spitzencluster "Personalisierte Medizin"
, Biotechnik, BioM Biotech Cluster Development GmbH
In den letzten Tagen konnten gleich 3 Projekte "nahezu auf ein Mal" die Arbeit aufnehmen, weil sie im Münchner Spitzenclusterprogramm "m4 - Personalisierte Medizin"...
|
|
Despite Strong CEE Performance, EMEA PC Shipments Decline by 6.5% in 4Q11, as Weakness in Western Europe Continues, Says IDC
, Finanzen / Bilanzen, IDC Central Europe GmbH
As expected, PC shipments in Europe, the Middle East, and Africa (EMEA) continued to contract in 4Q11 as sustained weakness in consumer demand and a slowdown in...
|
AiCuris' HCMV Drug Letermovir (AIC246) Receives Fast Track from FDA
, Forschung und Entwicklung, AiCuris GmbH & Co. KG
AiCuris announced today that the Food and Drug Administration (FDA) of the United States has granted Fast Track designation for one of the company's lead drugs,...
|
Roche's xCELLigence MP Instrument Used in the First Human Kinome Screen for Dynamic RNA Inhibitor Phenotypes during Cell Proliferation
, Forschung und Entwicklung, Roche Diagnostics GmbH
RNA interference studies are a powerful technology for high-throughput screening. However, endpoint analyses only provide a snapshot of the analyzed cellular phenotype,...
|
|
AiCuris' Novel HSV Compound AIC316 Shows Efficacy in Phase II
, Forschung und Entwicklung, AiCuris GmbH & Co. KG
Phase II results for AiCuris' novel non-nucleosidic herpes simplex virus (HSV) inhibitor AIC316 reveal safety and efficacy in persons with genital herpes. The data...
|
Gartner Says Worldwide PC Shipments Increased 2.3 Per Cent in Second Quarter of 2011
, Finanzen / Bilanzen, Gartner UK Ltd
Worldwide PC shipments surpassed 85.2 million units in the second quarter of 2011, a 2.3 per cent increase from the same period last year, according to preliminary...
|
|
AiCuris receives Orphan Drug Designation for its innovative phase II drug AIC246 for the prevention of HCMV disease
, Forschung und Entwicklung, AiCuris GmbH & Co. KG
AiCuris announced today that AIC246, the Company's inhibitor against the human cytomegalovirus HCMV, currently undergoing phase IIb testing, has been granted Orphan...
|
|
AiCuris erhält Orphan Drug Status für die innovative Phase II Substanz AIC246 gegen das Humanan Cytomegalievirus HCMV
, Forschung und Entwicklung, AiCuris GmbH & Co. KG
AiCuris teilte heute mit, dass der HCMV Inhibitor AIC246 von der Europäischen Kommission Orphan Drug Status für die Prävention von HCMV Erkrankungen erhalten hat....
|
|
Gartner Says Worldwide PC Shipments in First Quarter of 2011 Suffer First Year-Over-Year Decline in Six Quarters
, Finanzen / Bilanzen, Gartner UK Ltd
Worldwide PC shipments totalled 84.3 million units in the first quarter of 2011, a 1.1 per cent decline from the first quarter of 2010, according to preliminary...
|
|
Gartner Says Android to Command Nearly Half of Worldwide Smartphone Operating System Market by Year-End 2012
, Finanzen / Bilanzen, Gartner UK Ltd
Worldwide smartphone sales will reach 468 million units in 2011, a 57.7 per cent increase from 2010, according to Gartner Inc. By the end of 2011, Android will move...
|
|
Cloud Adoption Will Have Major Impact on European Software Market in 2011, According to IDC
, Events, IDC Central Europe GmbH
According to a new study from International Data Corporation (IDC), the cloud - packaged software solutions licensed as subscriptions and delivered over the Internet...
|
Gesund durch Fettabsaugung?
, Forschung und Entwicklung, Musenhof Deidesheim GmbH & Co. KG
Grundsätzlich kann man davon ausgehen, dass sich Übergewicht dann einstellt, wenn die dem Körper zugeführte Energiemenge größer ist, als die vom Körper verbrauchte...
|
|
AiCuris Announces AIC246 to be Successful in Treatment of Multiorgan HCMV Disease
, Forschung und Entwicklung, AiCuris GmbH & Co. KG
AiCuris announced today that its novel HCMV inhibitor AIC246 has been used successfully to treat a patient with multi-organ HCMV disease caused by multi-resistant...
Firmen
Kategorien
- Forschung und Entwicklung (12)
- Biotechnik (9)
- Finanzen / Bilanzen (7)
- FirmenIntern (4)
- Sicherheit (3)
Alle Kategorien
